LIPOCINE INC.
Patent Owner
Stats
- 20 US PATENTS IN FORCE
- 20 US APPLICATIONS PENDING
- Mar 15, 2018 most recent publication
Details
- 20 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 7,868 Total Citation Count
- Feb 26, 1999 Earliest Filing
- 44 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0319,596 METHODS FOR IMPROVING QUALITY OF LIFE OR SEXUAL DOMAIN FUNCTION AND COMPOSITION USEFUL IN THE METHODSNov 10, 16Nov 09, 17[A61K]
2017/0246,187 (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USEAug 28, 15Aug 31, 17[A61K, C07J]
2017/0035,781 17-HYDROXYPROGESTERONE ESTER-CONTAINING ORAL COMPOSITIONS AND RELATED METHODSJun 22, 16Feb 09, 17[A61K]
2017/0020,893 LIPOBALANCED LONG CHAIN TESTOSTERONE PRODRUGS FOR ORAL DELIVERYApr 26, 16Jan 26, 17[A61K]
2017/0007,623 17-HYDROXYPROGESTERONE ESTER-CONTAINING ORAL COMPOSITIONS AND RELATED METHODSSep 15, 16Jan 12, 17[A61K]
2016/0213,686 17-HYDROXYPROGESTERONE ESTER-CONTAINING ORAL COMPOSITIONS AND RELATED METHODSApr 05, 16Jul 28, 16[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9399069 17-Hydroxyprogesterone ester containing oral compositions and related methodsFeb 27, 15Jul 26, 16[A61K, A61Q]
9364547 17-hydroxyprogesterone ester containing oral compositions and related methodsApr 24, 14Jun 14, 16[A61K, A61Q]
9358298 17-hydroxyprogesterone ester containing oral compositions and related methodsSep 04, 14Jun 07, 16[A61K, A61Q]
9358299 17-hydroxyprogesterone ester-containing oral compositions and related methodsJul 16, 15Jun 07, 16[A61K, A61Q]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0367,569 HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONSAbandonedAug 14, 15Dec 22, 16[A61K]
2016/0361,322 COMPOSITION AND METHOD FOR ORAL DELIVERY OF ANDROGEN PRODRUGSAbandonedJun 15, 16Dec 15, 16[A61J, A61K, B65D]
2016/0193,225 (17-ß)-3-OXOANDROST-4-EN-17-YL UNDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USEAbandonedAug 31, 15Jul 07, 16[A61K]
2016/0193,228 LIPOBALANCED LONG CHAIN TESTOSTERONE ESTERS FOR ORAL DELIVERYAbandonedFeb 04, 16Jul 07, 16[A61K]
2016/0030,583 PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASEAbandonedMay 11, 15Feb 04, 16[A61K]
2016/0015,649 PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGSAbandonedJun 05, 15Jan 21, 16[A61K]
2015/0374,826 PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGSAbandonedSep 08, 15Dec 31, 15[A61K]
2015/0320,765 HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONSAbandonedJul 16, 15Nov 12, 15[A61K]
2015/0224,130 Solid Carriers for Improved Delivery of Active Ingredients in Pharmaceutical CompositionsAbandonedAug 14, 14Aug 13, 15[A61K]
2015/0064,243 PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMININISTRATION OF HYDROPHOBIC DRUGSAbandonedNov 07, 14Mar 05, 15[A61K]
2014/0323,453 LIPOBALANCED LONG CHAIN TESTOSTERONE ESTERS FOR ORAL DELIVERYAbandonedJun 30, 14Oct 30, 14[A61K]
2014/0309,202 HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONSAbandonedJun 06, 14Oct 16, 14[A61K]
2014/0303,132 LIPOBALANCED LONG CHAIN TESTOSTERONE ESTERS FOR ORAL DELIVERYAbandonedMay 30, 14Oct 09, 14[A61K]
2014/0288,039 LIPOBALANCED LONG CHAIN TESTOSTERONE PRODRUGS FOR ORAL DELIVERYAbandonedMay 30, 14Sep 25, 14[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.